SecBot SecBot
8-K ·Filed May 7, 2026

GOVX

GeoVax Labs, Inc.
BEARISH
Impact 7/10
Horizonweeks Processed5mo ago SEC0001437749-26-015613
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▼ Bearish

The immediate cash exercise provides a small liquidity boost, but the 2:1 warrant coverage and pending shareholder vote create a heavy overhang. Watch for the shareholder meeting date (by June 17) and any further Nasdaq delisting updates. The stock may face continued pressure from the dilutive warrant structure and delisting risk.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
GOVX ▼ -54.37% at T+60d
SHORT call ✓ call won +54.37% · α vs SPY +59.21% · entry $1.67 → $0.7620
Entry = T+0 close
May 7, 2026
via day close
T+1d
-11.38%
call +11.38% · α +11.61%
$1.48
settled 6mo ago
T+5d
-24.55%
call +24.55% · α +26.01%
$1.26
settled 6mo ago
T+20d
-1.20%
call +1.20% · α +1.22%
$1.65
settled 5mo ago
T+60d
-54.37%
call +54.37% · α +59.21%
$0.7620
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

GeoVax entered into a warrant inducement agreement with institutional holders to immediately exercise existing warrants for ~$595K in gross proceeds, issuing new unregistered warrants for 2x the exercised shares at $1.65/strike, exercisable only after Nasdaq shareholder approval. The $5M market-cap company is using the cash for working capital while facing a Nasdaq delisting notice, and the new warrants represent massive potential dilution (~200% of shares exercised) with no near-term exercisability until a shareholder meeting by June 17, 2026.

Key Financial Metrics

Deal Value
$595.0K
Offering Size
$595.0K

Key Facts

  • Gross proceeds of ~$595,000 from immediate cash exercise of 501,144 existing warrants at $1.1877/share
  • Issuance of 1,002,288 new unregistered warrants (200% of exercised shares) at $1.65 exercise price, exercisable only after Nasdaq shareholder approval
  • New warrants have 5-year term from stockholder approval date; company must hold shareholder meeting by June 17, 2026
  • Company is currently subject to a Nasdaq delisting notice (disclosed in the inducement letter)
  • A.G.P./Alliance Global Partners receives 7.0% cash fee (~$41,650) plus up to $40,000 expense reimbursement
  • Proceeds used for working capital and general corporate purposes
  • Resale registration statement for new warrant shares must be filed within 20 days of closing (May 8, 2026)

Financial Impact

~$595K gross cash infusion offset by massive future dilution: 1,002,288 new warrant shares at $1.65 strike, representing ~20%+ of current shares outstanding (based on $5M market cap at ~$0.50/share implied).

dilutioncashshareholder equity

Risk Factors

  • Massive potential dilution from 1,002,288 new warrants exercisable at $1.65, well above current trading levels
  • Nasdaq delisting notice creates existential risk for the listing
  • Shareholder approval required for warrant exercisability — failure would render new warrants worthless
  • Small $595K gross proceeds insufficient to fund clinical-stage operations for long

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-015613
Exhibit: ex_958826.htm0001437749-26-015613
Exhibit: ex_958827.htm0001437749-26-015613
Document: govx20260507_8k.htm0001437749-26-015613
Document: 0001437749-26-015613-index-headers.html0001437749-26-015613
Document: 0001437749-26-015613-index.html0001437749-26-015613
Document: 0001437749-26-015613.txt0001437749-26-015613
10 reports for GOVX
Performance horizon
100% Hit rate @ T+60 5 of 5 directional calls Went positive at some point 6 of 6 best @ T+60▲ +67.80%May 19, 2026
Filters
Rows
Reports for GOVX — sortable, filterable
TypeNow
Oct 27, 2026
today
8-K
BEARISH ★ 6/10
$0.2032awaiting T+60—$0.2010 (+1.08%)
Sep 24, 2026
4w ago
EFFECT
BEARISH ★ 6/10
$0.3603awaiting T+60—$0.2010 (+44.21%)
Jun 4, 2026
20w ago
EFFECT
BEARISH ★ 5/10
$1.79 $0.7210▲ +59.72%▲ +61.60%$0.2010 (+88.77%)
May 26, 2026
22w ago
S-1
NEUTRAL ★ 3/10
$3.49 $0.5947▼ −82.96%▼ −85.68%$0.2010 (−94.24%)
May 19, 2026
23w ago
8-K
BEARISH ★ 7/10
$2.23 $0.7180▲ +67.80%▲ +72.81%$0.2010 (+90.99%)
May 14, 2026
23w ago
8-K
BEARISH ★ 7/10
$1.23 $0.7700▲ +37.40%▲ +41.91%$0.2010 (+83.66%)
May 7, 2026
24w ago
8-K
BEARISH ★ 7/10
$1.67 $0.7620▲ +54.37%▲ +59.21%$0.2010 (+87.96%)
Apr 22, 2026
26w ago
EFFECT
NEUTRAL ★ 5/10
$1.17 $0.9742▼ −16.73%▼ −21.51%$0.2010 (−82.82%)
Apr 20, 2026
27w ago
EFFECT
BEARISH ★ 6/10
$1.17 $1.01▲ +13.68%▲ +20.45%$0.2010 (+82.82%)
Apr 15, 2026
27w ago
8-K
BEARISH ★ 7/10
$1.23 $1.11▲ +9.76%▲ +16.80%$0.2010 (+83.66%)
Showing 10 of 10

US Market Status

Market Closed — Opens Thu (11h 5m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 7, 2026